Jane Street Group LLC Reduces Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Jane Street Group LLC lowered its stake in shares of ZimVie Inc. (NASDAQ:ZIMV) by 60.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 18,881 shares of the company’s stock after selling 28,460 shares during the period. Jane Street Group LLC owned approximately 0.07% of ZimVie worth $263,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. Dimensional Fund Advisors LP boosted its position in shares of ZimVie by 9.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company’s stock worth $17,367,000 after purchasing an additional 107,461 shares during the period. American Century Companies Inc. boosted its position in shares of ZimVie by 23.9% during the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company’s stock worth $8,761,000 after purchasing an additional 121,053 shares during the period. Gamco Investors INC. ET AL boosted its position in shares of ZimVie by 15.1% during the 4th quarter. Gamco Investors INC. ET AL now owns 519,112 shares of the company’s stock worth $7,242,000 after purchasing an additional 68,176 shares during the period. Northern Trust Corp boosted its position in shares of ZimVie by 3.5% during the 4th quarter. Northern Trust Corp now owns 326,252 shares of the company’s stock worth $4,551,000 after purchasing an additional 10,988 shares during the period. Finally, Russell Investments Group Ltd. boosted its position in shares of ZimVie by 1.7% during the 4th quarter. Russell Investments Group Ltd. now owns 276,443 shares of the company’s stock worth $3,856,000 after purchasing an additional 4,739 shares during the period. Hedge funds and other institutional investors own 95.63% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on ZIMV. UBS Group lowered their price objective on shares of ZimVie from $16.00 to $10.00 and set a “neutral” rating for the company in a research report on Thursday, May 15th. B. Riley began coverage on shares of ZimVie in a research report on Thursday, April 10th. They set a “buy” rating and a $16.00 price objective for the company. Finally, Needham & Company LLC reiterated a “hold” rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Price Performance

ZimVie stock opened at $9.28 on Wednesday. The firm has a market cap of $258.42 million, a PE ratio of -0.71 and a beta of 2.16. ZimVie Inc. has a 52-week low of $8.15 and a 52-week high of $22.40. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. The company’s 50 day moving average is $9.21 and its two-hundred day moving average is $12.02.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Thursday, May 8th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.06. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The company had revenue of $112.00 million for the quarter, compared to analyst estimates of $113.10 million. On average, research analysts expect that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.